|Articles|March 6, 2006
- Applied Clinical Trials-03-06-2006
- Volume 0
- Issue 0
Interview with Klaus Rose
ACT had a chance to catch up with Dr. Rose, MD, MS, Head Pediatrics, F. Hoffmann-La Roche Ltd, Pharmaceutical Division.
Advertisement
Articles in this issue
over 19 years ago
Fighting for Europe's Futureover 19 years ago
Oracle Introduces Oracle® Clinical Data Repositoryover 19 years ago
Pictures from Parisover 19 years ago
EU Innovation and CompetitivenessNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
3
FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains
4
ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
